Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans

Daniel Espes1,2, Mats Martinell3, Hanna Liljebäck4

  • 1Department of Medical Cell Biology, Uppsala University, BMC, Husargatan 3, Box 571, Uppsala, SE-75123, Sweden. Daniel.Espes@mcb.uu.se.

Current Diabetes Reports
|October 14, 2015
PubMed

Insights

Betatrophin, a hormone, shows promise for treating type 2 diabetes by stimulating beta cell proliferation. This review explores its potential role in humans, offering hope for a cure.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Research

Background:

  • Type 2 diabetes prevalence is rising globally, with current treatments lacking a cure.
  • Increasing beta cell mass is a potential curative strategy for type 2 diabetes.
  • Limited data exists on human beta cell proliferation compared to rodents.

Purpose of the Study:

  • To review existing clinical data on the hormone betatrophin.
  • To discuss the potential role of betatrophin in human diabetes treatment.

Main Methods:

  • Literature review of preclinical and clinical studies on betatrophin.
  • Analysis of betatrophin's effects on beta cell proliferation and glucose metabolism.

Main Results:

  • Betatrophin demonstrated potent beta cell proliferation in mice.
  • Preclinical findings suggest betatrophin counteracts insulin resistance-induced glucose intolerance.

Conclusions:

  • Betatrophin represents a promising new target for diabetes drug development.
  • Further clinical research is needed to validate betatrophin's efficacy and safety in humans.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K